Bay Street News, May, 2024

State-of-the-art test facility to be a cornerstone of the Lilium Jet certification program Located at Lilium’s headquarters near Munich (Germany), […]

ONTARIO, Calif., May 16, 2024 (GLOBE NEWSWIRE) — Nature’s Miracle Holding Inc. (NASDAQ: NMHI; NMHIW) (“Nature’s Miracle” or the “Company”), […]

Dr. Philip B. Adamson will join as Chief Medical Officer Bonnie Handke will join as Senior Vice President of Patient […]

HEAWELL AI’s Clinical Co-Pilot technology participated in recently published evidence showing the integration of a highly accurate machine model for […]

Tel Aviv, Israel, May 16, 2024 (GLOBE NEWSWIRE) — Jeffs’ Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), […]

Transformational year thanks to successful organic growth and the benefit of acquisitions First quarter profit at the top end of […]

BOSTON, May 16, 2024 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (“Monte Rosa”) (Nasdaq: GLUE), a clinical-stage biotechnology company developing […]

ALACHUA, Fla. and TAMPA, Fla., May 16, 2024 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing […]

Rebranding introduced as Company advances toward Phase 3 clinical trial with lead asset – latiglutenase for the treatment of celiac […]

– First patient dosed in trial to evaluate the safety, pharmacokinetics and pharmacodynamics of TOUR006 in patients with inflammatory risk […]